Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT LP | 11-14-2023 | 09-30-2023 | 49 | 1,714,347,327 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 1 | $464,099,700 | 8,142,100 | 0.03 | 0.02 | 0 | 0.00 | 09-30-2023 |
| BRIDGEBIO PHARMA INC | COM | 2 | $122,950,916 | 4,662,530 | 0.01 | 0.00 | -317,449 | -6.37 | 09-30-2023 |
| AMBRX BIOPHARMA INC | SPONSORED ADS | 3 | $114,122,424 | 9,923,689 | 0.01 | 0.01 | 307,534 | 3.20 | 09-30-2023 |
| ARCELLX INC | COMMON STOCK | 4 | $77,142,000 | 2,150,000 | 0.00 | 0.00 | 150,000 | 7.50 | 09-30-2023 |
